Showing results (1-10 of 15) with videos related to
Sort By:
Pageof 2
Haemophilia : the Official Journal of the World Federation of Hemophilia|September 17, 2008
Pathogen safety of plasma-derived products - Haemate P/Humate-PA GrönerVox Sanguinis|December 16, 1998
GB virus C/hepatitis G virus and intravenous immunoglobulinsC Nübling, A Gröner, J LöwerVox Sanguinis|June 17, 2014
Defining acceptable epidemiology ranges in donor populations based on the contamination risk of finished plasma-derived productsS Lovick, K Bycholski, A GrönerApplied and Environmental Microbiology|April 1, 1983
Safety evaluation of nuclear polyhedrosis virus replication in pigsG Döller, A Gröner, O C StraubBiologicals : Journal of the International Association of Biological Standardization|September 10, 2002
Purity of spiking agent affects partitioning of prions in plasma protein purificationM Vey, H Baron, T Weimer, et al.Transfusion|January 5, 2002
High-titer screening PCR: a successful strategy for reducing the parvovirus B19 load in plasma pools for fractionationT Weimer, S Streichert, C Watson, et al.Intervirology|January 1, 1984
Interaction of Autographa californica nuclear polyhedrosis virus with two nonpermissive cell linesA Gröner, R R Granados, J P BurandThrombosis and Haemostasis|December 16, 2014
Safety of fibrinogen concentrate: analysis of more than 27 years of pharmacovigilance dataC Solomon, A Gröner, J Ye, et al.Transfusion|October 6, 1997
Analysis of human plasma products: polymerase chain reaction does not discriminate between live and inactivated virusesJ Hilfenhaus, A Gröner, T Nowak, et al.The Journal of General Virology|June 18, 2003
Improved conformation-dependent immunoassay: suitability for human prion detection with enhanced sensitivityA Bellon, W Seyfert-Brandt, W Lang, et al.Pageof 2